1
|
Shin D, Yoon BI, Kim S, Piao J, Jeon KH, Kwon Y, Park SH, Koo YT, Kim JS, Lee DS, Ha US, Kim SW, Jang H, Bae WJ. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial. Prostate Int 2023; 11:222-227. [PMID: 38196553 PMCID: PMC10772165 DOI: 10.1016/j.prnil.2023.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/21/2023] [Accepted: 09/04/2023] [Indexed: 01/11/2024] Open
Abstract
Background To evaluate the efficacy and safety of Cervi Parvum Cornu, Angelicae Gigantis Radix and Glycyrrhizae Radix complex (CAG) in men with moderate lower urinary tract symptoms (LUTS). Materials and methods From November 2020 to January 2022, participants with International Prostate Symptom Score (IPSS) of 12-19 in two centers were recruited and randomize into three groups: a CAG 500 mg/day group (CAG 500), a CAG 1000 mg/day group (CAG 1000), and a placebo group (PG). They were treated for 12 weeks. The primary endpoint was change of IPSS at the end of study from baseline. Secondary end points included change of prostate specific antigen (PSA), testosterone, dihydrotestosterone (DHT), maximum urinary flow rate (Q max), post-void residual volume (PVR), International Index of Erectile Function (IIEF), and drug safety. Results A total of 103 patients were able to finish the study according to the study protocol. Total IPSS and sub-scores (residual urine sensation, frequency, weak stream, hesistancy, nocturia, and quality of life) in CAG 500 and CAG 1000 were significantly improved at the 12th week compared to those of the PG. Changes of serum PSA, DHT, and testosterone levels at the 12th week from baseline did not show significant differences among the three groups. Q max and PVR changes did not show significant differences among the three groups either. Total IIEF and sub-scores (erectile function, orgasmic function, sexual desire, intercourse satisfaction) in CAG 1000 were significantly improved at 12th week compared to those in PG. No significant adverse events were found. Conclusions CAG is well tolerated in patients with moderate LUTS. Treatment with CAG for 12 weeks has a therapeutic effect on moderate LUTS.
Collapse
Affiliation(s)
- Dongho Shin
- Department of Urology, College of Medicine, Catholic Kwandong University, Incheon, Korea
| | - Byung Il Yoon
- Department of Urology, College of Medicine, Catholic Kwandong University, Incheon, Korea
| | - Soomin Kim
- Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Korea
| | - JunJie Piao
- Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Korea
| | - Kyung-Hwa Jeon
- College of Pharmacy, Ewha Womans University, Seoul, Korea
| | - Youngjoo Kwon
- College of Pharmacy, Ewha Womans University, Seoul, Korea
| | - Sang-Hyuck Park
- Institute of Cannabis Research, Colorado State University Pueblo, Pueblo, CO, USA
| | | | - Jin-Soo Kim
- Kwang Dong Pharmaceutical Co, Ltd., Seoul, Korea
| | - Dong Sup Lee
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - U-Syn Ha
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Sae Woong Kim
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea
- Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Korea
- Green Medicine Co., Ltd, Pusan, Korea
| | - Hoon Jang
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Woong Jin Bae
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea
- Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Korea
| |
Collapse
|
2
|
Kim JH, Jeong M, Doo EH, Koo YT, Lee SJ, Jang JW, Park JHY, Huh CS, Byun S, Lee KW. Glycine max Fermented by a Novel Probiotic, Bifidobacterium animalis subsp. lactis LDTM 8102, Increases Immuno-Modulatory Function. J Microbiol Biotechnol 2022; 32:1146-1153. [PMID: 36168203 PMCID: PMC9628972 DOI: 10.4014/jmb.2206.06038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Revised: 08/25/2022] [Accepted: 08/29/2022] [Indexed: 12/15/2022]
Abstract
Many probiotic species have been used as a fermentation starter for manufacturing functional food materials. We have isolated Bifidobacterium animalis subsp. lactis LDTM 8102 from the feces of infants as a novel strain for fermentation. While Glycine max has been known to display various bioactivities including anti-oxidant, anti-skin aging, and anti-cancer effects, the immune-modulatory effect of Glycine max has not been reported. In the current study, we have discovered that the extract of Glycine max fermented with B. animalis subsp. lactis LDTM 8102 (GFB 8102), could exert immuno-modulatory properties. GFB 8102 treatment increased the production of immune-stimulatory cytokines in RAW264.7 macrophages without any noticeable cytotoxicity. Analysis of the molecular mechanism revealed that GFB 8102 could upregulate MAPK2K and MAPK signaling pathways including ERK, p38, and JNK. GFB 8102 also increased the proliferation rate of splenocytes isolated from mice. In an animal study, administration of GFB 8102 partially recovered cyclophosphamide-mediated reduction in thymus and spleen weight. Moreover, splenocytes from the GFB 8102-treated group exhibited increased TNF-α, IL-6, and IL-1β production. Based on these findings, GFB 8102 could be a promising functional food material for enhancing immune function.
Collapse
Affiliation(s)
- Jae Hwan Kim
- Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea,Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea
| | - Minju Jeong
- Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea
| | - Eun-Hee Doo
- Department of Yuhan Biotechnology, School of Bio-Health Sciences, Yuhan University, Bucheon 14780, Republic of Korea
| | - Young Tae Koo
- Natural Products Convergence R&D Division, Kwangdong Pharm Co. Ltd., Republic of Korea
| | - Seon Joo Lee
- Natural Products Convergence R&D Division, Kwangdong Pharm Co. Ltd., Republic of Korea
| | - Ji Won Jang
- Natural Products Convergence R&D Division, Kwangdong Pharm Co. Ltd., Republic of Korea
| | - Jung Han Yoon Park
- Bio-MAX Institute, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Chul Sung Huh
- Research Institute of Eco-friendly Livestock Science, Institute of Green-Bio Science and Technology, Seoul National University, Pyeongchang 25354, Republic of Korea,Graduate School of International Agricultural Technology, Seoul National University, Pyeongchang 25354, Republic of Korea
| | - Sanguine Byun
- Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea,
S. Byun Phone: +82-2-2123-5896 E-mail:
| | - Ki Won Lee
- Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea,Bio-MAX Institute, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea,Advanced Institutes of Convergence Technology, Seoul National University, Suwon 16229, Republic of Korea,Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul 08826, Republic of Korea,Corresponding author K.W. Lee Phone: +82-2-880-4662 E-mail:
| |
Collapse
|
3
|
Huang WY, Youk JS, Han BK, Heo W, Yun BS, Kim JS, Koo YT, Hwang KA, Yoon JA, Kim YJ. Improvement of Fatigue Symptoms and Endurance Capacity by the Combined Administration of Cervus elaphus L., Angelica gigas Nakai, and Astragalus membranaceus Bunge. J Med Food 2021; 24:577-585. [PMID: 34161165 DOI: 10.1089/jmf.2020.4743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Fatigue is a common phenomenon usually observed in healthy, as well as in nonhealthy, individuals that affects their performance and quality of life. Efficient supplementation to relieve fatigue is of significant importance. This study was designed to investigate the efficacy of three prescreened natural resources (Cervus elaphus L. [CEL], Angelica gigas Nakai [AGN], and Astragalus membranaceus Bunge [AMB]) against fatigue symptoms induced by heavy exercise. Effects on muscle fatigue and endurance capacity during exercise were investigated in C2C12 myoblasts and exercised mice. A combination of CEL, AGN, and AMB (CEL:AGN:AMB, 1:2:1) treatment in myoblasts reduced intracellular reactive oxygen species levels induced by hydrogen peroxide by ∼20 times (P < .001). The optimal mixture extract combination was determined as CEL:AGN:AMB, 1:2:1 (CAA), which was recombined by applying the extraction yield of individual substance for in vivo study. Compared to the exercise control (EC) group, the serum lactate dehydrogenase level decreased by ∼40% due to CAA administration. The proliferator-activated receptor gamma coactivator 1-alpha protein expression increased significantly (P < .05) after CAA administration compared to that observed in the normal control group. In parallel, CAA treatment significantly (P < .05) enhanced the maximum running time compared to the EC group. Overall, combinatorial administration exhibited greater efficacy compared to each individual treatment, indicating that CAA could be used as an efficient ergogenic and antifatigue supplement.
Collapse
Affiliation(s)
- Wen Yan Huang
- Department of Food and Biotechnology, Korea University, Sejong, Korea
| | - Jin Soo Youk
- Department of Food and Biotechnology, Korea University, Sejong, Korea
| | - Bok Kyung Han
- Department of Food and Biotechnology, Korea University, Sejong, Korea
| | - Wan Heo
- Department of Food Science and Engineering, School of Convergence Bioscience and Technology, Seowon University, Chungcheongbuk-do, Korea
| | - Beom Sik Yun
- R&D Center, Kwangdong Pharm Co., Ltd., Seoul, Korea
| | - Jin Soo Kim
- R&D Center, Kwangdong Pharm Co., Ltd., Seoul, Korea
| | | | - Kyung-A Hwang
- Department of Agrofood Resources, National Institute of Agricultural Sciences, Rural Development Administration, Jeollabuk-do, Korea
| | - Jin A Yoon
- Department of Food and Nutrition, KC University, Seoul, Korea
| | - Young Jun Kim
- Department of Food and Biotechnology, Korea University, Sejong, Korea
| |
Collapse
|
4
|
Nam YH, Hong BN, Rodriguez I, Park MS, Jeong SY, Lee YG, Shim JH, Yasmin T, Kim NW, Koo YT, Lee SH, Paik DH, Jeong YJ, Jeon H, Kang SC, Baek NI, Kang TH. Steamed Ginger May Enhance Insulin Secretion through K ATP Channel Closure in Pancreatic β-Cells Potentially by Increasing 1-Dehydro-6-Gingerdione Content. Nutrients 2020; 12:E324. [PMID: 31991895 PMCID: PMC7071297 DOI: 10.3390/nu12020324] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Revised: 01/22/2020] [Accepted: 01/23/2020] [Indexed: 02/07/2023] Open
Abstract
Ginger (Zingiber officinale Roscoe) and its active compounds (gingerols, shogaols and paradols) have been reported as having beneficial functions for several diseases, including diabetes. In this study, we revealed that the steaming process could enhance the anti-diabetic potential of ginger. To confirm the anti-diabetic effect of steamed ginger extract (GG03), we assessed pancreatic islets impaired by alloxan in zebrafish and demonstrated anti-hyperglycemic efficacy in a mouse model. The EC50 values of ginger extract (GE) and GG03 showed that the efficacy of GG03 was greater than that of GE. In addition, LC50 values demonstrated that GG03 had lower toxicity than GE, and the comparison of the Therapeutic Index (TI) proved that GG03 is a safer functional food. Furthermore, our data showed that GG03 significantly lowered hyperglycemia in a diabetic mouse model. HPLC was performed to confirm the change in the composition of steamed ginger. Interestingly, GG03 showed a 375% increase in 1-dehydro-6-gingerdione (GD) compared with GE. GD has not yet been studied much pharmacologically. Thus, we identified the protective effects of GD in the damaged pancreatic islets of diabetic zebrafish. We further assessed whether the anti-diabetic mechanism of action of GG03 and GD involves insulin secretion. Our results suggest that GG03 and GD might stimulate insulin secretion by the closure of KATP channels in pancreatic β-cells.
Collapse
Affiliation(s)
- Youn Hee Nam
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Bin Na Hong
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Isabel Rodriguez
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Min Seon Park
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Seo Yule Jeong
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Yeong-Geun Lee
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Ji Heon Shim
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Tamanna Yasmin
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Na Woo Kim
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Young Tae Koo
- Kwang-Dong Pharmaceutical Co., Ltd., Seoul 06650, Korea; (Y.T.K.); (S.H.L.); (D.-H.P.)
| | - Sang Hun Lee
- Kwang-Dong Pharmaceutical Co., Ltd., Seoul 06650, Korea; (Y.T.K.); (S.H.L.); (D.-H.P.)
| | - Dong-Hyun Paik
- Kwang-Dong Pharmaceutical Co., Ltd., Seoul 06650, Korea; (Y.T.K.); (S.H.L.); (D.-H.P.)
| | - Yong Joon Jeong
- Research Institute, Genencell Co. Ltd., Yongin 16950, Gyeonggi-do, Korea; (Y.J.J.); (H.J.)
| | - Hyelin Jeon
- Research Institute, Genencell Co. Ltd., Yongin 16950, Gyeonggi-do, Korea; (Y.J.J.); (H.J.)
| | - Se Chan Kang
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Nam-In Baek
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| | - Tong Ho Kang
- Department of Oriental Medicine Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Gyeonggi-do, Korea; (Y.H.N.); (B.N.H.); (I.R.); (M.S.P.); (S.Y.J.); (Y.-G.L.); (J.H.S.); (T.Y.); (N.W.K.); (S.C.K.); (N.-I.B.)
| |
Collapse
|
5
|
Park B, Kwon JE, Cho SM, Kim CW, Lee DE, Koo YT, Lee SH, Lee HM, Kang SC. Protective effect of Lespedeza cuneata ethanol extract on Bisphenol A-induced testicular dysfunction in vivo and in vitro. Biomed Pharmacother 2018; 102:76-85. [PMID: 29549731 DOI: 10.1016/j.biopha.2018.03.045] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 03/09/2018] [Accepted: 03/09/2018] [Indexed: 11/25/2022] Open
Abstract
PURPOSE Bisphenol A (BPA) has been regarded as a possible risk factor for reproductive health. We examined potential reproductive health benefits of Lespedeza cuneata ethanol extract (LCE). Previously, Lespedeza cuneata showed many therapeutic effects. However, the protective effect of LCE on BPA-induced testicular dysfunction and its mechanisms have not been precisely studied. METHODS Mice were randomly divided into six groups (n = 7). Sperm counts and motility were measured by light microscope. Testosterone, total cholesterol, triglycerides, HDL, LDL-cholesterol, glucose, free fatty acids, hs-CRP, Angiotensinogen, Angiotensin II, GOT, GPT, TBARS, GSH, CAT, and SOD1 were measured in mouse serum. The potential protective effects of the LCE on mouse sertoli cells were evaluated. RESULTS Oral administration of LCE in BPA-exposed male mice restored testis weight, sperm count, motility, and testosterone levels by inhibiting markers in serum. In addition, treatment with LCE in BPA-treated TM4 sertoli cells recovered cell viability by attenuating Bax expression and activating caspase 3 and PARP. CONCLUSIONS These results indicate that LCE prevented BPA-induced testicular dysfunction and cell viability in BPA-treated TM4 sertoli cells. Our study also suggests that LCE has the potential to protect male reproductive health.
Collapse
Affiliation(s)
- Bongkyun Park
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
| | - Jeong Eun Kwon
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
| | - Se Min Cho
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
| | - Chang Won Kim
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
| | - Da Eun Lee
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
| | - Young Tae Koo
- Kwang-Dong Pharmaceutical Co., Ltd., Seoul 06650, Republic of Korea
| | - Sang Hun Lee
- Kwang-Dong Pharmaceutical Co., Ltd., Seoul 06650, Republic of Korea
| | - Hyun Myung Lee
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
| | - Se Chan Kang
- Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.
| |
Collapse
|